USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules’ Generic Amphetamine XR

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA12 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA12 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA13 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA14 hours ago 0